D-α-Methyl DOPA
D-α-Methyl DOPA is an inhibitor of the binding of DQ8 peptide to MHC class II molecules. D-α-Methyl DOPA occupies a pocket along the DQ8 peptide binding groove. D-α-Methyl DOPA inhibits the binding of a DQ8 peptide to an MHC class II molecule for presentation to CD4+ T cells, thereby slowing the development or progression of type 1 diabete or celiac disease[1].
Product Specifications
CAS Number
[2799-15-7]
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
MHC
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology; Metabolic Disease
Smiles
OC1=CC(=CC=C1O)C[C@](N)(C)C(O)=O
Molecular Formula
C10H13NO4
Molecular Weight
211.21
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501
References & Citations
[1]Peter A, et al. Methods of treating autoimmune disease. WO2017165508A1. WIPO (PCT) . 2017-03-22.
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Isoform
MHC II
Explore Other Products
Browse additional items from our catalog
Cluster of Differentiation 19 (CD19) Antibody (CF-Blue)
